{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:36:46Z","timestamp":1792510606133,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,2,18]],"date-time":"2010-02-18T00:00:00Z","timestamp":1266451200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Half of the familial aggregation of ovarian cancer can't be explained by any known risk genes, suggesting the existence of other genetic risk factors. Some of these unknown factors may not be traditional protein encoding genes. MicroRNA (miRNA) plays a critical role in tumorigenesis, but it is still unknown if variants in miRNA genes lead to predisposition to cancer. Considering the fact that miRNA regulates a number of tumor suppressor genes (TSGs) and oncogenes, genetic variations in miRNA genes could affect the levels of expression of TSGs or oncogenes and, thereby, cancer risk.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and Results<\/jats:title>\n            <jats:p>To test this hypothesis in familial ovarian cancer, we screened for genetic variants in thirty selected miRNA genes, which are predicted to regulate key ovarian cancer genes and are reported to be misexpressed in ovarian tumor tissues, in eighty-three patients with familial ovarian cancer. All of the patients are non-carriers of any known BRCA1\/2 or mismatch repair (MMR) gene mutations. Seven novel genetic variants were observed in four primary or precursor miRNA genes. Among them, three rare variants were found in the precursor or primary precursor of the miR-191 gene. In functional assays, the one variant located in the precursor of miR-191 resulted in conformational changes in the predicted secondary structures, and consequently altered the expression of mature miR-191. In further analysis, we found that this particular variant exists in five family members who had ovarian cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our findings suggest that there are novel genetic variants in miRNA genes, and those certain genetic variants in miRNA genes can affect the expression of mature miRNAs and, consequently, might alter the regulation of TSGs or oncogenes. Additionally, the variant might be potentially associated with the development of familial ovarian cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-10-47","type":"journal-article","created":{"date-parts":[[2010,2,18]],"date-time":"2010-02-18T19:15:43Z","timestamp":1266520543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Novel genetic variants in miR-191 gene and familial ovarian cancer"],"prefix":"10.1186","volume":"10","author":[{"given":"Jie","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"DiCioccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunle","family":"Odunsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashikant B","family":"Lele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,18]]},"reference":[{"issue":"2 Suppl","key":"1846_CR1","first-page":"517","volume":"71","author":"R Yancik","year":"1993","unstructured":"Yancik R: Ovarian cancer. Age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer. 1993, 71 (2 Suppl): 517-23.","journal-title":"Cancer"},{"key":"1846_CR2","first-page":"254","volume":"56","author":"SA Narod","year":"1995","unstructured":"Narod SA, Ford D, Devilee P, Barkardottir RB, Lynch HT, Smith SA, Ponder BAJ, Weber BL, Garber JE, Birch JM, Cornelis RS, Kelsell DP, Spurr NK, Smyth E, Haites N, Sobol H, Bignon Y-J, Chang-Claude J, Hamann U, Lindblom A, Borg A, Piver MS, Gallion HH, Struewing JP, Whittemore A, Tonin P, Goldgar DE, Easton DF: An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Am J Hum Genet. 1995, 56: 254-264.","journal-title":"Am J Hum Genet"},{"key":"1846_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet. 1998, 62: 676-689. 10.1086\/301749.","journal-title":"Am J Hum Genet"},{"key":"1846_CR4","first-page":"678","volume":"52","author":"DF Easton","year":"1993","unstructured":"Easton DF, Bishop DT, Ford D, Crockfor GF: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet. 1993, 52: 678-701.","journal-title":"Am J Hum Genet"},{"key":"1846_CR5","first-page":"589","volume":"59","author":"HT Lynch","year":"1982","unstructured":"Lynch HT, Albano WA, Lynch JF, Lynch PM, Campbell A: Surveillance and management of patients at high genetic risk for ovarian carcinoma. Obstet Gynecol. 1982, 59: 589-596.","journal-title":"Obstet Gynecol"},{"key":"1846_CR6","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM: A microRNA expression signature of human solid tumors define cancer gene targets. Proc Natl Acad Sci USA. 2006, 103: 2257-61. 10.1073\/pnas.0510565103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1846_CR7","doi-asserted-by":"publisher","first-page":"7004","DOI":"10.1073\/pnas.0801615105","volume":"105","author":"L Zhang","year":"2008","unstructured":"Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K, Johnstone CN, Megraw MS, Adams S, Lassus H, Huang J, Kaur S, Liang S, Sethupathy P, Leminen A, Simossis VA, Sandaltzopoulos R, Naomoto Y, Katsaros D, Gimotty PA, DeMichele A, Huang Q, B\u00fctzow R, Rustgi AK, Weber BL, Birrer MJ, Hatzigeorgiou AG, Croce CM, Coukos G: Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA. 2008, 105: 7004-9. 10.1073\/pnas.0801615105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1846_CR8","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/ijc.24008","volume":"124","author":"J Shen","year":"2009","unstructured":"Shen J, Ambrosone CB, Zhao H: Novel genetic variants in microRNA genes and familial breast cancer. Int J Cancer. 2009, 124: 1178-82. 10.1002\/ijc.24008.","journal-title":"Int J Cancer"},{"key":"1846_CR9","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1093\/carcin\/bgn172","volume":"29","author":"J Shen","year":"2008","unstructured":"Shen J, Ambrosone CB, DiCioccio RA, Odunsi K, Lele SB, Zhao H: A functional polymorphism in the miR-146a gene and age of familial breast\/ovarian cancer diagnosis. Carcinogenesis. 2008, 29: 1963-6. 10.1093\/carcin\/bgn172.","journal-title":"Carcinogenesis"},{"key":"1846_CR10","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1093\/carcin\/bgn195","volume":"29","author":"T Xu","year":"2008","unstructured":"Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, Ge YY, Yang JR, Su H, Zhuang SM: A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis. 2008, 29: 2126-31. 10.1093\/carcin\/bgn195.","journal-title":"Carcinogenesis"},{"key":"1846_CR11","doi-asserted-by":"publisher","first-page":"7269","DOI":"10.1073\/pnas.0802682105","volume":"105","author":"K Jazdzewski","year":"2008","unstructured":"Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A: Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA. 2008, 105: 7269-74. 10.1073\/pnas.0802682105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1846_CR12","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/ng2135","volume":"39","author":"N Iovino","year":"2007","unstructured":"Iovino N, Unnerstall U, Gaul U, Segal E: The role of site accessibility in microRNA target recognition. Nat Genet. 2007, 39: 1278-84. 10.1038\/ng2135.","journal-title":"Nat Genet"},{"key":"1846_CR13","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM: MIcroRNA signatures in human cancers. Nat Rev Cancer. 2006, 6: 857-866. 10.1038\/nrc1997.","journal-title":"Nat Rev Cancer"},{"key":"1846_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ajhg.2007.09.006","volume":"82","author":"IP Gorlov","year":"2008","unstructured":"Gorlov IP, Gorlova OY, Sunyaev SR, Spitz MR, Amos CI: Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am J Hum Genet. 2008, 82: 100-12. 10.1016\/j.ajhg.2007.09.006.","journal-title":"Am J Hum Genet"},{"key":"1846_CR15","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1093\/hmg\/ddm062","volume":"16","author":"R Duan","year":"2007","unstructured":"Duan R, Pak C, Jin P: Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet. 2007, 16: 1124-1131. 10.1093\/hmg\/ddm062.","journal-title":"Hum Mol Genet"},{"key":"1846_CR16","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1261\/rna.2780503","volume":"9","author":"Y Zheng","year":"2003","unstructured":"Zheng Y, Cullen BR: Sequence requirements for microRNA processing and function in human cells. RNA. 2003, 9: 112-123. 10.1261\/rna.2780503.","journal-title":"RNA"},{"key":"1846_CR17","first-page":"265","volume":"25","author":"HT Lynch","year":"1998","unstructured":"Lynch HT, Casey MJ, Lynch J, White TE, Godwin AK: Genetics and ovarian carcinoma. Semin Oncol. 1998, 25: 265-80.","journal-title":"Semin Oncol"},{"key":"1846_CR18","doi-asserted-by":"publisher","first-page":"9017","DOI":"10.1158\/0008-5472.CAN-06-0222","volume":"66","author":"T Pejovic","year":"2006","unstructured":"Pejovic T, Yates JE, Liu HY, Hays LE, Akkari Y, Torimaru Y, Keeble W, Rathbun RK, Rodgers WH, Bale AE, Ameziane N, Zwaan CM, Errami A, Thuillier P, Cappuccini F, Olson SB, Cain JM, Bagby GC: Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer. Cancer Res. 2006, 66: 9017-25. 10.1158\/0008-5472.CAN-06-0222.","journal-title":"Cancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-47.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-10-47\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-47","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-10-47.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T05:46:30Z","timestamp":1630475190000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-10-47"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,18]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1846"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-10-47","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,18]]},"assertion":[{"value":"11 June 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"47"}}